Estrogen Patch Shortage: What to Do If You Can’t Get Your Usual HRT

Estradiol patch shortages are leaving some women unable to fill their usual HRT prescriptions. Learn what is driving current supply issues, which products may be affected, what alternatives your pharmacist or provider may discuss, and why tracking symptoms and hormone patterns can be especially useful if your treatment changes.

Estradiol patch shortages are leaving some women unable to fill their usual HRT prescriptions. Learn what is driving current supply issues, which products may be affected, what alternatives your pharmacist or provider may discuss, and why tracking symptoms and hormone patterns can be especially useful if your treatment changes.
Estradiol patch shortages are leaving some women unable to fill their usual HRT prescriptions. Learn what is driving current supply issues, which products may be affected, what alternatives your pharmacist or provider may discuss, and why tracking symptoms and hormone patterns can be especially useful if your treatment changes.
If your pharmacy just told you your estradiol patch is unavailable, you're not imagining a supply problem, and you're not alone. Pharmacies across the country are reporting the same message: estradiol patches are on indefinite backorder, and the shortage affects all major brands, including Climara, Vivelle-Dot, and generics from Teva and Mylan.
This isn't a single pharmacy's inventory hiccup. It's a real, documented supply constraint, and it's worth understanding both why it's happening and what your actual options are if your usual prescription isn't available this month.
Why is there an estrogen patch shortage right now?
Two things are happening at once: demand has surged, and manufacturers haven't kept pace.
On the demand side, the number of women ages 45 to 54 prescribed estrogen-based therapies increased by 184% between 2018 and 2026, and prescriptions increased another 20% between July 2025 and February 2026 alone. Much of that growth traces back to a major shift in guidance and perception: the FDA's removal of the black box warning from estrogen products has made both patients and providers more comfortable prescribing hormone therapy. Women are also staying on treatment longer than earlier guidelines recommended, which means more people going back for refills rather than cycling off after a few years.
On the supply side, the picture is more fragmented. Sandoz has its 0.025 mg and 0.06 mg once-weekly patches on allocation, while its 0.0375 mg, 0.05 mg, 0.075 mg, and 0.1 mg once-weekly patches are on back order with no estimated release date. Some of this traces to ingredient sourcing, since many components used in estrogen patches are sourced overseas, and trade disruptions and manufacturing delays affecting those suppliers have contributed to the shortfall. The scale has grown quickly, as of July 1, 2026, 20 estrogen-patch formulations were listed as impacted by the shortage, double the number from earlier in the year, according to American Society of Health-System Pharmacists data.
The twice-weekly patch, one of the most commonly prescribed forms, was the first formulation affected, and it's used both for hot flashes and night sweats and for bone protection, which is part of why the disruption has felt so widespread.
How long will the estrogen patch shortage last? There's no confirmed end date. Some manufacturers have indicated the shortage is expected to continue through the end of 2026, with the increase in demand potentially extending supply constraints for up to three years. Availability may improve for some doses or brands before others, which is part of why a substitution today doesn't guarantee the same product will be available at your next refill.
What should you do if your estrogen patch is unavailable?
Before you do anything else: don't stop hormone therapy abruptly without talking to your prescriber, and don't assume the shortage means you're out of options. A few concrete steps:
- Call your pharmacy first, then try others. Availability is inconsistent by brand, dose, and location — a patch that's backordered at one pharmacy may be in stock at another, or under a different manufacturer's label for the same dose.
- Ask your prescriber about a different patch brand or dose at the same total dose. Not every brand is affected equally, and a therapeutically equivalent product may be available even when your specific one isn't.
- Ask whether a different delivery method makes sense for you right now. Oral estradiol, gels, and sprays are also options that some providers use as a bridge or ongoing alternative when patches aren't available. This is a conversation to have with your provider, not a swap to make on your own — different formulations are absorbed differently, and switching can change how much estrogen you're actually getting day to day. If your provider recommends switching delivery methods, our comparison of estradiol pills, patches, creams, and gels explains how absorption and dosing differ across each form.
- If you're also taking progesterone, ask your prescriber how to handle it if your estrogen supply is interrupted or your dose changes. Don't change either medication without their guidance, since progesterone protocols are often calibrated to your estrogen level.
- Check manufacturer patient assistance programs and 90-day mail-order fills if your pharmacy can access wider distribution channels than a local retail location.
If you switch formulations, what should you watch for?
This is the part that gets skipped in a lot of shortage coverage: switching products because of a supply issue is still a treatment change, and treatment changes don't always feel neutral.
Different estradiol formulations aren't absorbed identically. Pills pass through the liver first. Patches, gels, and creams deliver estrogen transdermally, but at different rates and consistency depending on skin, application site, and product design. Even when your provider switches you to an intended equivalent dose, a different delivery method may not feel identical. That's why some women feel fine after switching formulations, and others notice a shift in symptoms like hot flashes, sleep, or mood within the first couple of weeks, even though the prescription itself didn't change in intent.
Symptoms are important, but they may not tell you immediately whether a substitution is affecting you differently. If you do make a switch, it can help to track the change systematically. Our guide to how to know whether a hormone treatment is working walks through what to compare before and after, so you can evaluate the change more systematically instead of relying on memory alone.
How to track whether a new formulation is working?
If a shortage pushes you into a formulation you didn't choose, you won't know right away whether it's affecting you in the same way as your previous one. This is where daily hormone data can shorten the feedback loop. Oova's longitudinal hormone tracking shows how your estrogen pattern changes over time rather than relying on a single snapshot, so if a new patch, dose, or delivery method is behaving differently than your previous prescription, you have objective data to bring to your provider instead of a subjective sense that "something feels off." That's especially useful during a supply disruption, when you may be more likely to try more than one substitution before things stabilize.
If you specifically suspect your replacement dose isn't giving you the same symptom control, our piece on how to know if your HRT dose is right covers the specific signs to watch for.
The bottom line
The estrogen patch shortage is real, it's affecting multiple major brands and doses, and it's likely to continue for at least the rest of 2026. But a shortage doesn't mean you have to go without treatment, it means the conversation with your pharmacist and provider needs to happen sooner rather than later, and any formulation switch is worth watching closely rather than assuming it's a like-for-like swap.
FAQ Section
Is there an estrogen patch shortage right now?
Yes. As of July 2026, 20 estrogen-patch formulations were listed as affected by supply shortages, according to American Society of Health-System Pharmacists data, and the disruption affects all major brands, including Climara, Vivelle-Dot, and generics from Teva and Mylan.
Why are estradiol patches out of stock?
A combination of rising demand, driven in part by the FDA lifting its black box warning on estrogen products, and manufacturing or ingredient-sourcing constraints on the supply side.
What should I do if my estrogen patch is unavailable?
Contact your pharmacist to check other locations or manufacturers, and talk to your prescriber about an alternative brand, dose, or delivery method. Don't stop treatment abruptly without medical guidance.
Can I switch estrogen patch brands?
Often yes, if your provider confirms an equivalent dose is available. Not all brands are affected equally by the shortage.
Can I switch from an estrogen patch to gel or pills?
This is a decision to make with your provider, since absorption and dosing equivalence differ by formulation. It's a reasonable option to discuss if your usual patch isn't available.
Should I stop progesterone if I run out of estrogen patches?
Not without talking to your provider first. Progesterone protocols are often calibrated to your estrogen dose, so a change on one side may need an adjustment on the other.
How can I track whether a new HRT formulation is working?
Longitudinal hormone tracking can show how your estrogen pattern changes under the new formulation compared to your previous one, giving you and your provider objective data rather than relying on symptoms alone to catch a problem.
About the author

Sources
- American Society of Health-System Pharmacists, Drug Shortage Bulletin: Estradiol Transdermal System
- NBC News, "FDA claims there's no estrogen patch shortage as women struggle to get prescriptions filled" (May 2026)
- Midi Health, "Why Is There an Estrogen Patch Shortage? Causes & Solutions" (updated July 2026)
- SynergenX Health, "What to Know About the Current Estrogen Patch Shortage and What it Means for You" (May 2026)
- Cleopatra Rx, "Estradiol Patch Shortage 2026: Alternatives & What to Do Now" (July 2026)
- PBS NewsHour, "Estrogen patches face shortage as more women seek hormone therapy" (April 2026)
- Truveta prescription trend data (2018–2026), reported via NBC News
About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.
.jpg)

